Journal article
Procoagulant effects of lung cancer chemotherapy
Abstract
Lung cancer is the second leading type of cancer, with venous thromboembolism being the second leading cause of death. Studies have shown increased levels of microparticles and cell-free DNA (CFDNA) in cancer patients, which can activate coagulation through extrinsic and intrinsic pathways, respectively. However, the impact of lung cancer chemotherapy on microparticle and/or CFDNA generation is not completely understood. The aim of the study …
Authors
Lysov Z; Dwivedi DJ; Gould TJ; Liaw PC
Journal
Blood Coagulation & Fibrinolysis, Vol. 28, No. 1, pp. 72–82
Publisher
Wolters Kluwer
Publication Date
1 2017
DOI
10.1097/mbc.0000000000000546
ISSN
0957-5235